Cargando…
Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19
BACKGROUND: Thromboembolic disease is common in coronavirus disease-2019 (COVID-19). There is limited evidence on the association of in-hospital anticoagulation (AC) with outcomes and postmortem findings. OBJECTIVES: The purpose of this study was to examine association of AC with in-hospital outcome...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier on behalf of the American College of Cardiology Foundation
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449655/ https://www.ncbi.nlm.nih.gov/pubmed/32860872 http://dx.doi.org/10.1016/j.jacc.2020.08.041 |
_version_ | 1783574669987676160 |
---|---|
author | Nadkarni, Girish N. Lala, Anuradha Bagiella, Emilia Chang, Helena L. Moreno, Pedro R. Pujadas, Elisabet Arvind, Varun Bose, Sonali Charney, Alexander W. Chen, Martin D. Cordon-Cardo, Carlos Dunn, Andrew S. Farkouh, Michael E. Glicksberg, Benjamin S. Kia, Arash Kohli-Seth, Roopa Levin, Matthew A. Timsina, Prem Zhao, Shan Fayad, Zahi A. Fuster, Valentin |
author_facet | Nadkarni, Girish N. Lala, Anuradha Bagiella, Emilia Chang, Helena L. Moreno, Pedro R. Pujadas, Elisabet Arvind, Varun Bose, Sonali Charney, Alexander W. Chen, Martin D. Cordon-Cardo, Carlos Dunn, Andrew S. Farkouh, Michael E. Glicksberg, Benjamin S. Kia, Arash Kohli-Seth, Roopa Levin, Matthew A. Timsina, Prem Zhao, Shan Fayad, Zahi A. Fuster, Valentin |
author_sort | Nadkarni, Girish N. |
collection | PubMed |
description | BACKGROUND: Thromboembolic disease is common in coronavirus disease-2019 (COVID-19). There is limited evidence on the association of in-hospital anticoagulation (AC) with outcomes and postmortem findings. OBJECTIVES: The purpose of this study was to examine association of AC with in-hospital outcomes and describe thromboembolic findings on autopsies. METHODS: This retrospective analysis examined the association of AC with mortality, intubation, and major bleeding. Subanalyses were also conducted on the association of therapeutic versus prophylactic AC initiated ≤48 h from admission. Thromboembolic disease was contextualized by premortem AC among consecutive autopsies. RESULTS: Among 4,389 patients, median age was 65 years with 44% women. Compared with no AC (n = 1,530; 34.9%), therapeutic AC (n = 900; 20.5%) and prophylactic AC (n = 1,959; 44.6%) were associated with lower in-hospital mortality (adjusted hazard ratio [aHR]: 0.53; 95% confidence interval [CI]: 0.45 to 0.62 and aHR: 0.50; 95% CI: 0.45 to 0.57, respectively), and intubation (aHR: 0.69; 95% CI: 0.51 to 0.94 and aHR: 0.72; 95% CI: 0.58 to 0.89, respectively). When initiated ≤48 h from admission, there was no statistically significant difference between therapeutic (n = 766) versus prophylactic AC (n = 1,860) (aHR: 0.86; 95% CI: 0.73 to 1.02; p = 0.08). Overall, 89 patients (2%) had major bleeding adjudicated by clinician review, with 27 of 900 (3.0%) on therapeutic, 33 of 1,959 (1.7%) on prophylactic, and 29 of 1,530 (1.9%) on no AC. Of 26 autopsies, 11 (42%) had thromboembolic disease not clinically suspected and 3 of 11 (27%) were on therapeutic AC. CONCLUSIONS: AC was associated with lower mortality and intubation among hospitalized COVID-19 patients. Compared with prophylactic AC, therapeutic AC was associated with lower mortality, although not statistically significant. Autopsies revealed frequent thromboembolic disease. These data may inform trials to determine optimal AC regimens. |
format | Online Article Text |
id | pubmed-7449655 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Published by Elsevier on behalf of the American College of Cardiology Foundation |
record_format | MEDLINE/PubMed |
spelling | pubmed-74496552020-08-27 Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19 Nadkarni, Girish N. Lala, Anuradha Bagiella, Emilia Chang, Helena L. Moreno, Pedro R. Pujadas, Elisabet Arvind, Varun Bose, Sonali Charney, Alexander W. Chen, Martin D. Cordon-Cardo, Carlos Dunn, Andrew S. Farkouh, Michael E. Glicksberg, Benjamin S. Kia, Arash Kohli-Seth, Roopa Levin, Matthew A. Timsina, Prem Zhao, Shan Fayad, Zahi A. Fuster, Valentin J Am Coll Cardiol Original Investigation BACKGROUND: Thromboembolic disease is common in coronavirus disease-2019 (COVID-19). There is limited evidence on the association of in-hospital anticoagulation (AC) with outcomes and postmortem findings. OBJECTIVES: The purpose of this study was to examine association of AC with in-hospital outcomes and describe thromboembolic findings on autopsies. METHODS: This retrospective analysis examined the association of AC with mortality, intubation, and major bleeding. Subanalyses were also conducted on the association of therapeutic versus prophylactic AC initiated ≤48 h from admission. Thromboembolic disease was contextualized by premortem AC among consecutive autopsies. RESULTS: Among 4,389 patients, median age was 65 years with 44% women. Compared with no AC (n = 1,530; 34.9%), therapeutic AC (n = 900; 20.5%) and prophylactic AC (n = 1,959; 44.6%) were associated with lower in-hospital mortality (adjusted hazard ratio [aHR]: 0.53; 95% confidence interval [CI]: 0.45 to 0.62 and aHR: 0.50; 95% CI: 0.45 to 0.57, respectively), and intubation (aHR: 0.69; 95% CI: 0.51 to 0.94 and aHR: 0.72; 95% CI: 0.58 to 0.89, respectively). When initiated ≤48 h from admission, there was no statistically significant difference between therapeutic (n = 766) versus prophylactic AC (n = 1,860) (aHR: 0.86; 95% CI: 0.73 to 1.02; p = 0.08). Overall, 89 patients (2%) had major bleeding adjudicated by clinician review, with 27 of 900 (3.0%) on therapeutic, 33 of 1,959 (1.7%) on prophylactic, and 29 of 1,530 (1.9%) on no AC. Of 26 autopsies, 11 (42%) had thromboembolic disease not clinically suspected and 3 of 11 (27%) were on therapeutic AC. CONCLUSIONS: AC was associated with lower mortality and intubation among hospitalized COVID-19 patients. Compared with prophylactic AC, therapeutic AC was associated with lower mortality, although not statistically significant. Autopsies revealed frequent thromboembolic disease. These data may inform trials to determine optimal AC regimens. Published by Elsevier on behalf of the American College of Cardiology Foundation 2020-10-20 2020-08-26 /pmc/articles/PMC7449655/ /pubmed/32860872 http://dx.doi.org/10.1016/j.jacc.2020.08.041 Text en © 2020 Published by Elsevier on behalf of the American College of Cardiology Foundation. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Original Investigation Nadkarni, Girish N. Lala, Anuradha Bagiella, Emilia Chang, Helena L. Moreno, Pedro R. Pujadas, Elisabet Arvind, Varun Bose, Sonali Charney, Alexander W. Chen, Martin D. Cordon-Cardo, Carlos Dunn, Andrew S. Farkouh, Michael E. Glicksberg, Benjamin S. Kia, Arash Kohli-Seth, Roopa Levin, Matthew A. Timsina, Prem Zhao, Shan Fayad, Zahi A. Fuster, Valentin Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19 |
title | Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19 |
title_full | Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19 |
title_fullStr | Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19 |
title_full_unstemmed | Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19 |
title_short | Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19 |
title_sort | anticoagulation, bleeding, mortality, and pathology in hospitalized patients with covid-19 |
topic | Original Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449655/ https://www.ncbi.nlm.nih.gov/pubmed/32860872 http://dx.doi.org/10.1016/j.jacc.2020.08.041 |
work_keys_str_mv | AT nadkarnigirishn anticoagulationbleedingmortalityandpathologyinhospitalizedpatientswithcovid19 AT lalaanuradha anticoagulationbleedingmortalityandpathologyinhospitalizedpatientswithcovid19 AT bagiellaemilia anticoagulationbleedingmortalityandpathologyinhospitalizedpatientswithcovid19 AT changhelenal anticoagulationbleedingmortalityandpathologyinhospitalizedpatientswithcovid19 AT morenopedror anticoagulationbleedingmortalityandpathologyinhospitalizedpatientswithcovid19 AT pujadaselisabet anticoagulationbleedingmortalityandpathologyinhospitalizedpatientswithcovid19 AT arvindvarun anticoagulationbleedingmortalityandpathologyinhospitalizedpatientswithcovid19 AT bosesonali anticoagulationbleedingmortalityandpathologyinhospitalizedpatientswithcovid19 AT charneyalexanderw anticoagulationbleedingmortalityandpathologyinhospitalizedpatientswithcovid19 AT chenmartind anticoagulationbleedingmortalityandpathologyinhospitalizedpatientswithcovid19 AT cordoncardocarlos anticoagulationbleedingmortalityandpathologyinhospitalizedpatientswithcovid19 AT dunnandrews anticoagulationbleedingmortalityandpathologyinhospitalizedpatientswithcovid19 AT farkouhmichaele anticoagulationbleedingmortalityandpathologyinhospitalizedpatientswithcovid19 AT glicksbergbenjamins anticoagulationbleedingmortalityandpathologyinhospitalizedpatientswithcovid19 AT kiaarash anticoagulationbleedingmortalityandpathologyinhospitalizedpatientswithcovid19 AT kohlisethroopa anticoagulationbleedingmortalityandpathologyinhospitalizedpatientswithcovid19 AT levinmatthewa anticoagulationbleedingmortalityandpathologyinhospitalizedpatientswithcovid19 AT timsinaprem anticoagulationbleedingmortalityandpathologyinhospitalizedpatientswithcovid19 AT zhaoshan anticoagulationbleedingmortalityandpathologyinhospitalizedpatientswithcovid19 AT fayadzahia anticoagulationbleedingmortalityandpathologyinhospitalizedpatientswithcovid19 AT fustervalentin anticoagulationbleedingmortalityandpathologyinhospitalizedpatientswithcovid19 |